Neuroendocrine Tumors (NETs)
Neuroendocrine tumors (NETs) are rare cancers that arise from neuroendocrine cells, which are found in various organs, including the gastrointestinal tract, pancreas, and lungs. These tumors can be slow-growing (low-grade) or aggressive (high-grade), making early diagnosis critical for successful treatment.
Why Germany for NETs Treatment?
Germany is a global leader in the diagnosis and treatment of neuroendocrine cancer, offering:
Advanced imaging techniques for precise tumor detection
Innovative treatments, including PRRT (Peptide Receptor Radionuclide Therapy)
Minimally invasive & robotic-assisted surgical options
Access to cutting-edge clinical trials & personalized medicine
International patients benefit from Germany’s top specialists, state-of-the-art medical centers, and world-class neuroendocrine cancer treatment protocols.
Understanding Early-Stage Neuroendocrine Cancer
Stage 1 Neuroendocrine Cancer
- Tumor is small (≤2 cm) and confined to the originating organ.
- No spread to lymph nodes or distant sites.
- Typically low-grade (slow-growing) with a favorable prognosis.
Stage 2 Neuroendocrine Cancer
- Tumor is larger (>2 cm) but still localized within the organ.
- May involve nearby tissues but no distant metastases.
- Can be low-grade or intermediate-grade, requiring careful monitoring.
Why Early Detection Matters
Advanced imaging (68Ga-DOTATATE PET-CT, MRI, Endoscopic Ultrasound) detects NETs early.
Genetic testing & biomarker analysis (CgA, NSE, Ki-67) guide treatment planning.
Treatment Options for Stage 1 & 2 Neuroendocrine Cancer
Surgical Resection (Curative Option for Localized NETs)
- Procedure: Complete removal of the tumor while preserving organ function.
- Ideal for: Both Stage 1 & 2 NETs, particularly in the pancreas, intestines, or lungs.
- Cost: €18,000 – €65,000
- Prognosis: 90%+ survival rate for low-grade NETs after surgery.
Minimally Invasive & Robotic-Assisted Surgery
- Procedure: Laparoscopic or robotic techniques remove the tumor with minimal trauma.
- Ideal for: Small pancreatic or gastrointestinal NETs.
- Cost: €25,000 – €55,000
- Prognosis: High survival rates with quicker recovery.
Peptide Receptor Radionuclide Therapy (PRRT)
- Procedure: Radioactive molecules (Lutetium-177 DOTATATE) target NET cells, delivering precise radiation.
- Ideal for: NETs expressing somatostatin receptors (SSTR-positive tumors).
- Cost: €45,000 – €90,000 per treatment plan
- Prognosis: Significant tumor reduction & prolonged survival.
Somatostatin Analog Therapy (Octreotide & Lanreotide)
- Procedure: Inhibits tumor growth by blocking hormone production.
- Ideal for: Hormone-secreting NETs or slow-growing tumors.
- Cost: €3,000 – €9,000 per injection (long-term therapy may be required)
- Prognosis: Controls tumor growth, improving quality of life.
Targeted Therapy (Everolimus & Sunitinib)
- Procedure: Blocks tumor blood supply & growth pathways.
- Ideal for: Pancreatic NETs or progressive tumors.
- Cost: €55,000 – €95,000 per treatment plan
- Prognosis: Slows tumor progression and enhances survival.
Advanced & Emerging Neuroendocrine Cancer Treatments in Germany
PRRT: A Revolutionary Therapy for NETs
Peptide Receptor Radionuclide Therapy (PRRT) is one of the most effective and advanced treatments for NETs.
Uses Lutetium-177 DOTATATE to precisely target and destroy cancer cells while sparing healthy tissues.
Best for: Stage 2 or recurrent NETs with somatostatin receptor positivity.
Cost: €63,000 – €90,000 per treatment plan
Success Rate: Prolongs survival and reduces tumor burden in 70-90% of cases.
Leading PRRT Centers in Germany
Zentrum für Nuklearmedizin Bad Berka (ZNB) – Top PRRT center in Germany.
University Hospital Freiburg – Specialized in nuclear medicine for NETs.
University Hospital Munich (LMU Klinikum) – Advanced PRRT & imaging technologies.
Dendritic Cell Therapy for Neuroendocrine Cancer
Dendritic cells (DCs) are trained to stimulate the immune system against NETs.
Best for:
- Slow-growing NETs with residual disease after surgery.
- Patients seeking personalized immunotherapy options.
Cost: €30,000 – €55,000 per treatment plan
Success Rate: Boosts immune response & improves long-term disease control.
Leading Dendritic Cell Therapy Centers in Germany
University Hospital Heidelberg (NCT)
Charité – Universitätsmedizin Berlin
IOZK Cologne
Why Germany is the Best Destination for Neuroendocrine Cancer Treatment
State-of-the-art nuclear medicine & PRRT
Minimally invasive surgical techniques
Access to advanced clinical trials & targeted therapies
Personalized immunotherapy, including dendritic cell vaccines
Top NET Specialists in Germany
Prof. Dr. Richard P. Baum – ZNB Bad Berka (PRRT & Nuclear Medicine Expert).
Prof. Dr. Markus Schwaiger – University Hospital Munich (Nuclear Imaging & PRRT).
Prof. Dr. Andreas Pfestroff – University Hospital Freiburg (Neuroendocrine Surgery Specialist).
Prof. Dr. Ulrich-Frank Pape – Charité Berlin (Gastrointestinal NETs & Immunotherapy).
Conclusion
Germany is a global leader in neuroendocrine cancer treatment, offering high-precision diagnostics, PRRT, targeted therapy, and cutting-edge immunotherapy.
At WEGOVITA, we ensure that international patients receive the best medical care in Germany, providing:
Personalized medical consultations
Visa & travel support
Appointment scheduling with top specialists
Sources for Neuroendocrine Cancer Treatment
European Neuroendocrine Tumor Society (ENETS) – ENETS Guidelines
Zentrum für Nuklearmedizin Bad Berka (Germany) – ZNB Official Site
Heidelberg University Hospital (Germany) – Heidelberg Cancer Center
The Lancet Oncology & Journal of Clinical Oncology – PRRT & Targeted Therapy Research
National Cancer Institute (NCI, USA) – NCI NET Research
